Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022

SELL
$10.21 - $15.27 $4,788 - $7,161
-469 Closed
0 $0
Q3 2021

Oct 15, 2021

SELL
$14.07 - $17.3 $8,807 - $10,829
-626 Reduced 57.17%
469 $7,000
Q2 2021

Aug 06, 2021

BUY
$16.62 - $18.94 $249 - $284
15 Added 1.39%
1,095 $19,000
Q1 2021

May 07, 2021

SELL
$15.15 - $19.78 $183,693 - $239,832
-12,125 Reduced 91.82%
1,080 $19,000
Q4 2020

Feb 16, 2021

SELL
$16.86 - $19.67 $17,180 - $20,043
-1,019 Reduced 7.16%
13,205 $244,000
Q3 2020

Nov 09, 2020

BUY
$15.4 - $20.16 $11,657 - $15,261
757 Added 5.62%
14,224 $247,000
Q2 2020

Aug 05, 2020

BUY
$18.24 - $21.45 $7,897 - $9,287
433 Added 3.32%
13,467 $246,000
Q1 2020

May 05, 2020

BUY
$16.28 - $25.63 $4,623 - $7,278
284 Added 2.23%
13,034 $263,000
Q4 2019

Feb 14, 2020

SELL
$19.57 - $23.52 $1.39 Million - $1.67 Million
-71,138 Reduced 84.8%
12,750 $297,000
Q3 2019

Nov 14, 2019

BUY
$19.85 - $22.76 $1,052 - $1,206
53 Added 0.06%
83,888 $1.68 Million
Q2 2019

Aug 07, 2019

SELL
$17.59 - $21.1 $39,067 - $46,863
-2,221 Reduced 2.58%
83,835 $1.77 Million
Q1 2019

May 14, 2019

SELL
$18.01 - $20.11 $168,483 - $188,129
-9,355 Reduced 9.8%
86,056 $1.73 Million
Q4 2018

Feb 14, 2019

SELL
$17.44 - $21.53 $153,785 - $189,851
-8,818 Reduced 8.46%
95,411 $1.75 Million
Q3 2018

Nov 14, 2018

SELL
$19.97 - $21.96 $55,616 - $61,158
-2,785 Reduced 2.6%
104,229 $2.23 Million
Q2 2018

Aug 14, 2018

BUY
$20.16 - $24.68 $47,517 - $58,170
2,357 Added 2.25%
107,014 $2.3 Million
Q1 2018

May 15, 2018

BUY
$20.31 - $24.95 $60,787 - $74,675
2,993 Added 2.94%
104,657 $2.22 Million
Q4 2017

Feb 14, 2018

BUY
$20.99 - $23.89 $55,098 - $62,711
2,625 Added 2.65%
101,664 $2.33 Million
Q3 2017

Nov 14, 2017

BUY
$20.07 - $21.89 $75,322 - $82,153
3,753 Added 3.94%
99,039 $2.17 Million
Q2 2017

Aug 11, 2017

BUY
N/A
95,286
95,286 $2.01 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.